Deep brain stimulation in Parkinson's disease following fetal nigral transplantation

Jan Herzog, Oliver Pogarell, Marcus O. Pinsker, Andreas Kupsch, Wolfgang H. Oertel, Olle Lindvall, Guenther Deuschl, Jens Volkmann

    Research output: Contribution to journalArticlepeer-review

    Abstract

    OFF-period dyskinesias have been reported as a consequence of fetal nigral transplantation for Parkinson's disease. This type of dyskinesias may appear in patients even in the prolonged absence of antiparkinson medication and be aggravated by levodopa. Therefore, pharmacological therapeutic approaches in these patients are limited. Here we report two patients with bilateral fetal nigral grafts in the caudate and putamen subjected to deep brain stimulation (DBS) of the globus pallidus internus (GPi) or subthalamic nucleus (STN). Clinical assessment was performed according to UPDRS and the clinical dyskinesia rating scale. In both patients, we found significant improvement in OFF-period symptoms as well as levodopa-induced dyskinesias. However, only GPi-DBS led to a significant reduction of OFF-period dyskinesias whereas STN-DBS did not influence dyskinesias unrelated to external dopaminergic application. These findings, based on two case reports, highlight the pivotal role of the GPi in mediating dyskinesia-related neural activity within the basal ganglia loop. (C) 2008 Movement Disorder Society.
    Original languageEnglish
    Pages (from-to)1293-1296
    JournalMovement Disorders
    Volume23
    Issue number9
    DOIs
    Publication statusPublished - 2008

    Bibliographical note

    The information about affiliations in this record was updated in December 2015.
    The record was previously connected to the following departments: Restorative Neurology (0131000160)

    Subject classification (UKÄ)

    • Neurology

    Free keywords

    • deep brain stimulation
    • Parkinson's disease
    • neural transplantation
    • dyskinesias

    Fingerprint

    Dive into the research topics of 'Deep brain stimulation in Parkinson's disease following fetal nigral transplantation'. Together they form a unique fingerprint.

    Cite this